Underwriters advised on Almoosa Health Company IPO on Saudi Exchange

Eversheds Sutherland (International) LLP and Mohammed AlDhabaan & Partners Eversheds Sutherland (International) LLP advised Saudi Fransi Capital (as underwriter, bookrunner, financial advisor and lead manager) and EFG Hermes KSA (as underwriter and bookrunner), on the initial public offering (IPO) of Almoosa Health Company, a leading healthcare provider in Saudi Arabia, on the Main Market of the Saudi Exchange.

The IPO consisted of an offer, by way of a primary issuance and secondary sale, of a total of 13,291,074 ordinary shares, representing 30% of the total share capital of Almoosa Health Company, at a final offer price set at SAR 127 per share. The total offering value amounted to SAR 1.69 billion (US$449 million).

Almoosa Health Company operates primarily in the healthcare sector, providing integrated healthcare services, including primary care, critical care, and rehabilitation services. It also provides secondary services to this sector, such as pharmaceutical services, home healthcare, and telemedicine.

Eversheds Sutherland (International) LLP and Mohammed AlDhabaan & Partners Eversheds Sutherland (International) LLP deal team was led by Partners Greg Stonefield and Walid Salib, with primary support from Senior Associate Raja Ghandour and Associate Faisal Al Shaikh.